Literature DB >> 11913540

Latent activity of curcumin against leishmaniasis in vitro.

Danish Saleheen1, Syed Atif Ali, Khalid Ashfaq, Anwar Al Siddiqui, Ajmal Agha, Muhammad Masoom Yasinzai.   

Abstract

In this study the anti-proliferative effect of curcumin (curcuma longa) that is the active ingredient of ground dried rhizome has been studied against three local and three reference leishmanial strains, Leishmania major, Leishmania tropica and Leishmania infantum (Pakistani isolate). Curcumin has shown an average IC50 of 5.3 microM against promastigotes of various leishmanial strains which is much lower as compared with pentamidine that is one of the basic treatments against leishmaniasis. The main draw back attributed to these assays performed on promastigotes is the heterogeneity of results compared with those obtained with intracellular amastigotes or with in vivo effect. We also tested activity of curcumin against axenic amastigote like cells (AALC) of L. major strain (MHOM/PK/88/DESTO). Curcumin proves to be far more potent then pentamidine against AALC which further strengthens the fact about its leishmaniacidal activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11913540     DOI: 10.1248/bpb.25.386

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  14 in total

1.  Epigenetic changes induced by curcumin and other natural compounds.

Authors:  Simone Reuter; Subash C Gupta; Byoungduck Park; Ajay Goel; Bharat B Aggarwal
Journal:  Genes Nutr       Date:  2011-04-24       Impact factor: 5.523

2.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

3.  Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents.

Authors:  D E Said; L M Elsamad; Y M Gohar
Journal:  Parasitol Res       Date:  2012-03-06       Impact factor: 2.289

4.  Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species.

Authors:  Long Cui; Jun Miao; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

5.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

6.  Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model.

Authors:  Nagasuresh Adapala; Marion M Chan
Journal:  Lab Invest       Date:  2008-09-15       Impact factor: 5.662

7.  Liposomal formulation of turmerone-rich hexane fractions from Curcuma longa enhances their antileishmanial activity.

Authors:  Ana Claudia F Amaral; Luciana A Gomes; Jefferson Rocha de A Silva; José Luiz P Ferreira; Aline de S Ramos; Maria do Socorro S Rosa; Alane B Vermelho; Igor A Rodrigues
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

Review 8.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

9.  In vitro study of parasite elimination and endothelial protection by curcumin: adjunctive therapy for cerebral malaria.

Authors:  Sarun Kunwittaya; Lertyot Treeratanapiboon; Apapan Srisarin; Chartchalerm Isarankura-Na-Ayudhya; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-03-20       Impact factor: 4.068

10.  Curcumin is a promising inhibitor of genotype 2 porcine reproductive and respiratory syndrome virus infection.

Authors:  Taofeng Du; Yunpeng Shi; Shuqi Xiao; Na Li; Qin Zhao; Angke Zhang; Yuchen Nan; Yang Mu; Yani Sun; Chunyan Wu; Hongtao Zhang; En-Min Zhou
Journal:  BMC Vet Res       Date:  2017-10-10       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.